searchCabergolineSystematic (IUPAC) nameN-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]- 6-(2-propenyl)-8g-ergoline-8-carboxamideor1-[(6-allylergolin8?-yl)- carbonyl]-1- [3-(dimethylamino)propyl]-3-ethylureaIdentifiersCAS number 81409-90-7ATC code G02CB03 N04BC06PubChem 54746DrugBank.

hydrolysis of dostinex et prise de poids acylurea bond or the urea moietyHalf life 63-69 hours (estimated)Excretion Urine (22%), feces (60%)Therapeutic considerationsPregnancy cat. C(US)Legal status ?-only(US)Routes OralCabergoline (brand names dostinex et prise de poids and Cabaser®), a lysergic acid amide derivative, is a potent dopamine receptor agonist on D2 dostinex et prise de poids It also has been suggested online that it counteracts certain side effects were extremely frequent. Fifty-three percent of patients reported side effects. Very frequent: Nausea (30%), obstipation (22%), and dry mouth (10%). Frequent: Gastric irritation (7%), vomiting (5%), dostinex et prise de poids dyspepsia (2%).Psychiatric disturbances and central nervous system (CNS): Altogether 51 percent of patients experienced side effects. Very frequent: Sleep disturbances (somnolence 18%, insomnia 11%), vertigo (27%), dostinex et prise de poids depression (13%). Frequent: dyskinesia dostinex et prise de poids and hallucinations (4%).Cardiovascular: Approximately 30 percent of patients were affected. Very frequent: Nausea dostinex et prise de poids obstipation (22%), and dry mouth (10%).

to 4.5 mg per week, slowly titrated to 4.5 mg per week, if necessary.Ablactation: According dostinex et prise de poids specific treatment scheme.[edit] References^.